Zepp Health Corporation Sponsored ADR ZEPP
- Market cap
- $34.9M
- P/E
- 0.0×
Follow ZEPP
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | 33.72 | 29.08 | 35.00 | 17.04 | 4.20 | 3.86 | 2.06 | 2.13 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | 60.36 | 78.64 | 72.82 | 81.00 | 21.56 | 8.76 | 8.40 | 61.85 |
High Price
|
|||
| 376 | 416 | 694 | 1,132 | 1,507 | 1,227 | 987 | 839 | 765 | 763 |
Employees
|
|||
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| 234 | 315 | 530 | 835 | 986 | 981 | 601 | 353 | 183 | 259 |
Revenue
|
|||
| 17.74% | 24.14% | 25.77% | 25.25% | 20.71% | 20.89% | 19.39% | 26.17% | 38.46% | 38.31% |
Gross Margin
|
|||
| 4 | 29 | 56 | 94 | 41 | 17 | (54) | (35) | (58) | (35) |
EBT
|
|||
| 1.85% | 9.37% | 10.61% | 11.22% | 4.13% | 1.71% | (8.99%) | (9.81%) | (31.71%) | (13.70%) |
EBT Margin
|
|||
| 4 | 26 | 49 | 82 | 35 | 21 | (42) | (31) | (76) | (40) |
Net Income
|
|||
| 0 | 1 | 1 | 2 | 4 | 8 | 8 | 8 | 5 | 5 |
Depreciation
|
|||
| 67.31 | 74.34 | 40.04 | 54.83 | 63.49 | 62.23 | 39.02 | 23.22 | 11.29 | 16.28 |
Revenue/Sh
|
|||
| 1.04 | 1.68 | 3.48 | 5.40 | 2.24 | 1.36 | (2.72) | (1.96) | (4.68) | (2.52) |
Earnings/Sh
|
|||
| 0.75 | 8.65 | 7.77 | 4.04 | 1.55 | (2.31) | (7.42) | 2.80 | (1.51) | (1.62) |
Cash Flow/Sh
|
|||
| (0.50) | (0.78) | (0.76) | (0.43) | (0.84) | (0.50) | (0.09) | 0.20 | 0.02 | (0.01) |
Capex/Sh
|
|||
| 0.25 | 7.87 | 7.01 | 3.60 | 0.72 | (2.82) | (7.51) | 3.00 | (1.49) | (1.63) |
Free CF/Sh
|
|||
| 1.30 | 8.28 | 19.88 | 23.56 | 26.94 | 29.21 | 25.29 | 23.21 | 15.62 | 13.49 |
Book Value/Sh
|
|||
| 3 | 4 | 13 | 15 | 16 | 16 | 15 | 15 | 16 | 16 |
Shares
|
|||
| 0.00 | 0.13 | 11.54 | 8.97 | 21.94 | 19.80 | 0.00 | 0.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| 0.00 | 0.00 | 0.98 | 0.88 | 0.75 | 1.32 | 0.16 | 0.25 | 0.23 | 1.65 |
PS Ratio
|
|||
| 0.00 | 0.02 | 1.98 | 2.04 | 1.76 | 2.79 | 0.25 | 0.25 | 0.17 | 2.00 |
PB Ratio
|
|||
| 0.00 | 0.00 | 0.54 | 0.58 | 0.48 | 1.28 | 0.32 | 0.18 | 0.26 | 1.66 |
EV/Sales
|
|||
| 0.00 | 0.00 | 2.14 | 2.56 | 3.10 | 8.17 | 4.52 | (15.95) | (0.57) | (3.59) |
EV/FCF
|
|||
| 3 | 37 | 103 | 61 | 24 | (36) | (114) | 43 | (24) | (26) |
Op' Cash Flow
|
|||
| (2) | (3) | (10) | (7) | (13) | (8) | (1) | 3 | 0 | 0 |
Capex
|
|||
| 1 | 33 | 93 | 55 | 11 | (44) | (116) | 46 | (24) | (26) |
FCF
|
|||
| 34 | 64 | 214 | 274 | 312 | 279 | 187 | 162 | 56 | 7 |
Working Cap'
|
|||
| 2 | 6 | 6 | 16 | 94 | 201 | 245 | 122 | 117 | 115 |
Total Debt
|
|||
| (23) | (53) | (227) | (246) | (259) | (40) | 99 | (24) | 5 | 2 |
Net Debt
|
|||
| 5 | 35 | 263 | 359 | 418 | 460 | 389 | 353 | 253 | 215 |
Sh' Equity
|
|||
| (0.98%) | 3.82% | 4.72% | 13.52% | 4.25% | 2.33% | (4.86%) | (4.43%) | (13.01%) | (7.33%) |
ROA
|
|||
| 0.00% | 0.00% | 91.68% | 48.12% | 10.44% | 2.19% | (7.62%) | (5.79%) | (11.44%) | (8.43%) |
ROIC
|
|||
| (9.29%) | 35.79% | 11.07% | 26.46% | 9.02% | 4.92% | (9.84%) | (8.36%) | (25.02%) | (17.15%) |
ROE
|
|||
Zepp Health Corporation Sponsored ADR peers in Consumer Electronics
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| KOSS Koss Corporation | $39.8M | 0.0× | Compare |
| AXIL AXIL Brands, Inc. | $42.2M | 16.1× | Compare |
| UEIC Universal Electronics Inc. | $67.7M | 0.0× | Compare |
| FOXX Foxx Development Holdings Inc. | $17.4M | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| MSN Emerson Radio Corporation | $10.0M | 0.0× | Compare |
| TBCH Turtle Beach Corporation | $228.7M | 0.0× | Compare |
| VUZI Vuzix Corporation | $231.3M | 0.0× | Compare |
| GPRO GoPro, Inc. | $237.7M | 0.0× | Compare |
Zepp Health Corporation Sponsored ADR (ZEPP) key facts
- Zepp Health Corporation Sponsored ADR (ZEPP) is a Consumer Electronics company in the Technology sector, traded in the US as an ADR.
- Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024.
- As of September 25, 2026, ZEPP traded at $4.14, a market capitalization of $34.9 million.
- Return on equity was −17.2% and debt-to-equity 0.72.
Zepp Health Corporation Sponsored ADR (ZEPP) Latest News
22 Sep
Amazfit, a Zepp Health-owned brand, unveils the T-Rex Dual Solar, the first AMOLED smartwatch with dual-sided solar charging. Front solar on the display and a larger rear glass-ceramic back panel extend battery life beyond typical 25 days, with three hours of 50,000 lux daily exposure boosting endurance to up to 34 days on the front; rear solar provides even more energy. Features include a 1.32-inch, up to 3,000-nit AMOLED display, 10 ATM water resistance, 50-meter diving support, a built-in flashlight, and GPS/navigation tools with preloaded maps and LiveShare. Solar Priority and Expedition modes optimize power for multi-day trips. Specs emphasize titanium bezel, sapphire crystal, 660 mAh battery, and up to 41 hours in GPS mode; price $649.99, available Sept 22, 2026 on Amazfit.com and Amazon. Dual-sided solar AMOLED watch expands product differentiation and could boost sales and investor sentiment.
2 Sep
Zepp Health returns to growth in Q2 2026 amid supply challenges. Return to growth signals potential recovery in financial performance despite supply constraints.
1 Sep
Zepp Health Corporation Sponsored ADR (ZEPP) Q2 earnings call highlights financial results and operational updates. Q2 earnings call highlights deliver performance data and guidance that moderately shift near-term investor views.
Zepp Health Corporation released unaudited financial results for the second quarter of 2026. Quarterly earnings reports can shift short-term stock valuation based on reported numbers.
18 Jun
Amazfit launches Helio Strap Pro body-worn device delivering movement intelligence for HYROX and hybrid training athletes. New product launch supports fitness tech innovation and may lift brand visibility and sales modestly.
9 Jun
Zepp Health reports strong revenue growth in Q1 2026 earnings call alongside strategic initiatives driving performance. Strong revenue growth and strategic moves in earnings call point to significant positive shifts in company trajectory.
8 Jun
Zepp Health Corporation released unaudited financial results for the first quarter of 2026. Quarterly results disclosures frequently shift investor sentiment and alter near-term stock valuation.
Zepp Health Q1 earnings call highlights financial results and operational updates for ZEPP ADR. Q1 earnings details deliver key financial metrics that typically influence short-term ZEPP stock sentiment without major strategic shifts.
2 Jun
Amazfit launches Balance 3 and Balance Ultra smartwatches to advance hybrid training features. New Amazfit Balance 3 and Balance Ultra launches represent significant product releases that can shift ZEPP competitive positioning.
13 May
Amazfit launched the Cheetah 2 Ultra, a performance trail running watch engineered for the toughest mountain trails with advanced features for extreme endurance. Amazfit's launch of a premium trail running watch strengthens Zepp Health's position in the competitive wearables market and could drive revenue growth.
11 May
Amazfit unveiled the Cheetah 2 Pro, a high-performance running watch designed for marathon preparation with advanced training metrics, AI coaching, and dual-band GPS. New Amazfit Cheetah 2 Pro launch targets competitive running segment, boosting Zepp Health's product portfolio and potential sales in wearables.
19 Apr
Loss-making Zepp Health Corporation (NYSE:ZEPP) is positioned to achieve breakeven, signaling a turnaround from ongoing losses. Breakeven trajectory for a loss-making company represents a major financial milestone that could boost stock performance and investor confidence.
16 Apr
Amazfit unveiled the Cheetah 2 Pro, a performance running watch built for marathon preparation with advanced training features. New high-end running watch launch targets competitive fitness segment and strengthens Amazfit's product portfolio for potential revenue growth.
15 Apr
HYROX and Amazfit strengthen their alliance through a global three-year partnership. Global three-year partnership with HYROX boosts Amazfit's fitness sector visibility and Zepp Health's competitive positioning.
17 Mar
Zepp Health Corp (ZEPP) reported strong revenue growth and strategic advancements in Q4 2025 earnings call highlights. Strong Q4 2025 revenue growth and strategic initiatives signal major positive shifts in ZEPP's financial trajectory and market positioning.
15 Mar
Zepp Health Corporation released Q4 earnings call highlights detailing financial results, operational updates, and forward-looking guidance. Q4 earnings call highlights reveal financial performance and strategic outlook, significantly impacting investor sentiment and stock trajectory.
Zepp Health Corporation announced unaudited financial results for Q4 and full year 2025. Q4 and full-year financial results directly impact stock price, investor sentiment, and valuation assessments.
26 Feb
Amazfit launched the Active 3 Premium smartwatch, targeting entry-level runners by transforming daily movement into meaningful progress with features like advanced training guidance, GPS tracking, and AI-powered coaching. New premium smartwatch launch for entry-level runners strengthens Amazfit's product lineup and could significantly enhance Zepp Health's revenue and competitive positioning in wearables.
20 Feb
Amazfit launched the T-Rex Ultra 2, a titanium GPS watch built for extreme adventures with advanced durability, multi-band GNSS, offline maps, and up to 27 days battery life. Premium rugged smartwatch launch bolsters Zepp Health's product portfolio and market position in wearables.
19 Feb
Amazfit announced the T-Rex Ultra 2, a titanium GPS watch engineered for extreme adventures, featuring advanced durability, 180-hour GPS battery life, offline maps, and dive capabilities up to 40 meters. Launch of a premium rugged smartwatch strengthens Amazfit's position in the extreme sports wearables market, likely boosting Zepp Health's sales and investor interest.
8 Jan
Amazfit has launched the Active Max, a new smartwatch designed for enhanced performance with a larger display and improved brightness. The device aims to cater to fitness enthusiasts by offering advanced tracking features and a robust design, positioning itself as a competitive option in the wearable technology market. The introduction of the Active Max is expected to moderately influence Zepp Health's competitive positioning and product innovation in the wearable market.
6 Jan
Amazfit, a brand under Zepp Health Corporation, unveiled its latest innovations in sports technology at CES 2026, showcasing advanced wearable devices designed to enhance athletic performance and health monitoring. The new products feature cutting-edge sensors and AI-driven analytics, aiming to set a new standard in the fitness tech industry. This launch positions Amazfit as a leader in the competitive landscape of sports technology, appealing to both professional athletes and fitness enthusiasts. The introduction of advanced sports technology products is likely to significantly impact Zepp Health's market positioning and investor sentiment.
30 Dec
Amazfit has launched the Active Max smartwatch, featuring a larger display, enhanced brightness, and advanced performance capabilities. The device is designed for fitness enthusiasts, offering improved tracking and user experience. This new addition aims to strengthen Amazfit's position in the competitive wearable market. The introduction of the Active Max smartwatch may enhance product innovation and competitive positioning but is not expected to drastically alter the company's overall trajectory.
5 Dec
Zepp Health Corporation Sponsored ADR (ZEPP) has achieved an astonishing nearly 1,100% gain, significantly outperforming the S&P 500. This remarkable performance is attributed to the company's innovative health technology products and strategic market positioning, which have resonated well with consumers and investors alike. As the demand for health-focused technology continues to rise, Zepp Health's growth trajectory appears promising, drawing attention from market analysts and investors seeking high-potential stocks. The significant gain and strategic positioning in a growing market indicate a likely substantial impact on future performance.
6 Nov
Zepp Health Corporation reported record revenue growth in Q3 2025, highlighting strategic initiatives that contributed to its performance. The company emphasized advancements in product innovation and market expansion, which have positively impacted its financial results. Management expressed optimism about future growth prospects and outlined plans for continued investment in technology and customer engagement. Record revenue growth and strategic initiatives indicate significant potential for future performance and market positioning.
Zepp Health Corporation (NYSE: ZEPP) reported a significant annual loss increase of 64.6%, raising concerns about its recovery prospects. The worsening financial performance has led to skepticism among investors regarding the company's ability to rebound in the competitive health technology market. The substantial increase in losses indicates a significant challenge to the company's recovery and future market performance.
4 Nov
Zepp Health Corporation reported its unaudited financial results for the third quarter of 2025, highlighting key metrics such as revenue growth and profitability. The company continues to expand its product offerings and market presence, reflecting a positive trajectory in its financial performance. Strategic initiatives and investments in technology are expected to drive future growth. Significant revenue growth and strategic initiatives indicate a likely positive shift in the company's market position.
20 Oct
Zepp Health Corporation will report its financial results for the third quarter of 2025 on November 4, 2025. Investors and analysts are likely to pay close attention to the results for insights into the company's performance and future outlook. Quarterly financial results can moderately influence investor sentiment and provide insights into the company's operational performance.
19 Oct
Zepp Health Corporation Sponsored ADR (ZEPP) has outperformed Apple in stock gains for 2025, attributed to its innovative fitness technology and strategic market positioning. The company's focus on health and wellness products has resonated well with consumers, leading to increased sales and investor interest. Analysts highlight Zepp's ability to capture market share in the competitive fitness tech sector, suggesting a strong growth trajectory compared to larger competitors like Apple. Zepp's innovative product offerings and market share growth are likely to significantly impact its future performance and investor sentiment.
29 Sep
Amazfit has expanded its HYROX athlete roster by signing global champions and rising stars, enhancing its brand presence in the fitness community. This initiative aims to promote the Amazfit brand and its products through partnerships with elite athletes, showcasing their commitment to fitness and performance. The expansion of the athlete roster may enhance brand visibility and market positioning, but its overall impact on financial performance is expected to be limited.